31
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Region of origin and cervical cancer stage in multiethnic Hispanic/Latinx patients living in the United States

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Hispanic/Latinx people have the second highest cervical cancer incidence rates in the U.S. However, there is a lack of disaggregated data on clinical outcomes for this diverse and populous group, which is critical to direct resources and funding where they are most needed. This study assessed differences in stage at diagnosis of cervical cancer among Hispanic/Latinx subpopulations and associated factors.

          Methods

          We analyzed patients with primary cervical cancer from 2004 to 2019 in the National Cancer Database. Hispanic/Latinx patients were further categorized into Mexican, Puerto Rican (PR), Cuban, Dominican, and Central/South American, as per standard NCDB categories, and evaluated based on stage at diagnosis and sociodemographic characteristics. Multinomial logistic regression quantified the odds of advanced stage at presentation. Regression models were adjusted for age, education, neighborhood income, insurance status, and additional factors.

          Results

          Hispanic/Latinx cervical cancer patients were more likely to be uninsured (18.9% vs. 6.0%, p < 0.001) and more likely to live in low‐income neighborhoods (28.6% vs. 16.9%, p < 0.001) when compared to non‐Hispanic White populations. Uninsured Hispanic/Latinx patients had 37.0% higher odds of presenting with regional versus localized disease (OR 1.37; 95% CI, 1.19–1.58) and 47.0% higher odds of presenting with distant versus. Localized disease than insured patients (OR 1.47; 95% CI, 1.33–1.62). When adjusting for age, education, neighborhood income, and insurance status, PR patients were 48% more likely than Mexican patients to present with stage IV versus stage I disease (OR 1.48; 95% CI, 1.34–1.64).

          Conclusion

          Disaggregating health data revealed differences in stage at cervical cancer presentation among Hispanic/Latinx subpopulations, with insurance status as a major predictor. Further work targeting structural factors, such as insurance status, within specific Hispanic/Latinx subpopulations is needed.

          Related collections

          Most cited references30

          • Record: found
          • Abstract: found
          • Article: not found
          Is Open Access

          Cancer statistics, 2023

          Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population-based cancer occurrence and outcomes using incidence data collected by central cancer registries and mortality data collected by the National Center for Health Statistics. In 2023, 1,958,310 new cancer cases and 609,820 cancer deaths are projected to occur in the United States. Cancer incidence increased for prostate cancer by 3% annually from 2014 through 2019 after two decades of decline, translating to an additional 99,000 new cases; otherwise, however, incidence trends were more favorable in men compared to women. For example, lung cancer in women decreased at one half the pace of men (1.1% vs. 2.6% annually) from 2015 through 2019, and breast and uterine corpus cancers continued to increase, as did liver cancer and melanoma, both of which stabilized in men aged 50 years and older and declined in younger men. However, a 65% drop in cervical cancer incidence during 2012 through 2019 among women in their early 20s, the first cohort to receive the human papillomavirus vaccine, foreshadows steep reductions in the burden of human papillomavirus-associated cancers, the majority of which occur in women. Despite the pandemic, and in contrast with other leading causes of death, the cancer death rate continued to decline from 2019 to 2020 (by 1.5%), contributing to a 33% overall reduction since 1991 and an estimated 3.8 million deaths averted. This progress increasingly reflects advances in treatment, which are particularly evident in the rapid declines in mortality (approximately 2% annually during 2016 through 2020) for leukemia, melanoma, and kidney cancer, despite stable/increasing incidence, and accelerated declines for lung cancer. In summary, although cancer mortality rates continue to decline, future progress may be attenuated by rising incidence for breast, prostate, and uterine corpus cancers, which also happen to have the largest racial disparities in mortality.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Structural racism and health inequities in the USA: evidence and interventions

            The Lancet, 389(10077), 1453-1463
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Cancer health disparities in racial/ethnic minorities in the United States

              There are well-established disparities in cancer incidence and outcomes by race/ethnicity that result from the interplay between structural, socioeconomic, socio-environmental, behavioural and biological factors. However, large research studies designed to investigate factors contributing to cancer aetiology and progression have mainly focused on populations of European origin. The limitations in clinicopathological and genetic data, as well as the reduced availability of biospecimens from diverse populations, contribute to the knowledge gap and have the potential to widen cancer health disparities. In this review, we summarise reported disparities and associated factors in the United States of America (USA) for the most common cancers (breast, prostate, lung and colon), and for a subset of other cancers that highlight the complexity of disparities (gastric, liver, pancreas and leukaemia). We focus on populations commonly identified and referred to as racial/ethnic minorities in the USA—African Americans/Blacks, American Indians and Alaska Natives, Asians, Native Hawaiians/other Pacific Islanders and Hispanics/Latinos. We conclude that even though substantial progress has been made in understanding the factors underlying cancer health disparities, marked inequities persist. Additional efforts are needed to include participants from diverse populations in the research of cancer aetiology, biology and treatment. Furthermore, to eliminate cancer health disparities, it will be necessary to facilitate access to, and utilisation of, health services to all individuals, and to address structural inequities, including racism, that disproportionally affect racial/ethnic minorities in the USA.
                Bookmark

                Author and article information

                Contributors
                atergas@coh.org
                Journal
                Cancer Med
                Cancer Med
                10.1002/(ISSN)2045-7634
                CAM4
                Cancer Medicine
                John Wiley and Sons Inc. (Hoboken )
                2045-7634
                15 November 2023
                December 2023
                : 12
                : 23 ( doiID: 10.1002/cam4.v12.23 )
                : 21452-21464
                Affiliations
                [ 1 ] Obstetrics, Gynecology and Women's Health Institute, Cleveland Clinic Cleveland Ohio USA
                [ 2 ] Columbia University College of Physicians and Surgeons New York New York USA
                [ 3 ] New York Presbyterian Hospital New York New York USA
                [ 4 ] Joseph L. Mailman School of Public Health Columbia University New York New York USA
                [ 5 ] Bouvé College of Health Sciences and College of Social Sciences and Humanities Northeastern University Boston Massachusetts USA
                [ 6 ] Division of Gynecologic Oncology, Department of Surgery City of Hope Comprehensive Cancer Center Duarte California USA
                [ 7 ] Division of Health Equity, Department of Population Science Beckman Research Institute, City of Hope Comprehensive Cancer Center Duarte California USA
                Author notes
                [*] [* ] Correspondence

                Ana I. Tergas, Division of Gynecologic Oncology, Department of Surgery, Division of Health Equity, Department of Population Science, Beckman Research Institute, City of Hope Comprehensive Cancer Center, Medical and Leadership Pavilion, Suite 2223, 1500 E. Duarte Rd, Duarte, CA 91010, USA.

                Email: atergas@ 123456coh.org

                Author information
                https://orcid.org/0000-0002-4390-5083
                https://orcid.org/0000-0002-8752-2498
                Article
                CAM46697 CAM4-2023-07-3557.R1
                10.1002/cam4.6697
                10726831
                37964735
                9609a69c-c76a-4699-8340-6d53cb8c435a
                © 2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 27 September 2023
                : 24 July 2023
                : 26 October 2023
                Page count
                Figures: 1, Tables: 3, Pages: 13, Words: 4861
                Funding
                Funded by: National Cancer Institute , doi 10.13039/100000054;
                Award ID: K08 CA245193‐01
                Categories
                Research Article
                RESEARCH ARTICLES
                Cancer Prevention
                Custom metadata
                2.0
                December 2023
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.3.6 mode:remove_FC converted:18.12.2023

                Oncology & Radiotherapy
                cervical cancer,health disparities,hispanic,latino/latinx
                Oncology & Radiotherapy
                cervical cancer, health disparities, hispanic, latino/latinx

                Comments

                Comment on this article